Affordable Access

deepdyve-link
Publisher Website

Immunohistochemical localization of nerve growth factor, tropomyosin receptor kinase A, and p75 in the bone and articular cartilage of the mouse femur.

Authors
  • Chartier, Stephane R1
  • Mitchell, Stefanie At1
  • Majuta, Lisa A1
  • Mantyh, Patrick W1, 2
  • 1 1 Department of Pharmacology, University of Arizona, Tucson, AZ, USA.
  • 2 2 Cancer Center, University of Arizona, Tucson, AZ, USA.
Type
Published Article
Journal
Molecular Pain
Publisher
SAGE Publications
Publication Date
Jan 01, 2017
Volume
13
Identifiers
DOI: 10.1177/1744806917745465
PMID: 29166838
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

Sequestration of nerve growth factor (NGF) significantly attenuates skeletal pain in both animals and humans. However, relatively little is known about the specific cell types that express NGF or its cognate receptors tropomyosin receptor kinase A (TrkA) and p75 in the intact bone and articular cartilage. In the present study, antibodies raised against NGF, TrkA, and p75 (also known as CD271) were used to explore the expression of these antigens in the non-decalcified young mouse femur. In general, all three antigens displayed a remarkably restricted expression in bone and cartilage with less than 2% of all DAPI+ cells in the femur displaying expression of any one of the three antigens. Robust NGF immunoreactivity was found in mostly CD-31- blood vessel-associated cells, a small subset of CD-31+ endothelial cells, an unidentified group of cells located at the subchondral bone/articular cartilage interface, and a few isolated, single cells in the bone marrow. In contrast, p75 and TrkA were almost exclusively expressed by nerve fibers located nearby NGF+ blood vessels. The only non-neuronal expression of either p75 or TrkA in the femur was the expression of p75 by a subset of cells located in the deep and middle zone of the articular cartilage. Understanding the factors that tightly regulate the basal level of expression in normal bone and how the expression of NGF, TrkA, and p75 change in injury, disease, and aging may provide insights into novel therapies that can reduce skeletal pain and improve skeletal health.

Report this publication

Statistics

Seen <100 times